CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)	Dec. 31, 2022	Mar. 31, 2022
Current assets:
Cash and cash equivalents	$ 35,951	$ 111,396
Account receivable	81	5,618
Prepayments and other receivables	0	4,419
Total current assets	36,032	121,433
TOTAL ASSETS	36,032	121,433
Current liabilities:
Accrued liabilities and other payables	279,510	54,779
Accrued marketing fee	226,366	226,366
Amount due to a director	78,862	64,365
Note payable, related party	133,557	133,557
Promissory notes, related parties	84,645	0
Total current liabilities	802,940	479,067
Long-term liabilities
Promissory notes, related parties	0	76,584
Total long-term liabilities	0	76,584
TOTAL LIABILITIES	802,940	555,651
Commitments and contingencies
STOCKHOLDERS’ DEFICIT
Common stock, $0.001 par value; 4,400,000,000 shares authorized; 831,310,013 shares issued and outstanding as of December 31, 2022 and March 31, 2022, respectively	831,310	831,310
Accumulated other comprehensive (loss) income	(2,567)	64
Accumulated deficit	(1,601,991)	(1,271,932)
Stockholders’ deficit	(766,908)	(434,218)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	36,032	121,433
Convertible Preferred Stock [Member]
STOCKHOLDERS’ DEFICIT
Preferred Stock, Value, Issued	0	0
Series A Preferred Stock [Member]
STOCKHOLDERS’ DEFICIT
Preferred Stock, Value, Issued	6,240	6,240
Series B Preferred Stock [Member]
STOCKHOLDERS’ DEFICIT
Preferred Stock, Value, Issued	$ 100	$ 100